Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy

BACKGROUND/AIMS: The ability of endoscopic submucosal dissection (ESD) to resect large early gastric cancers (EGCs) results in the need to treat large artificial gastric ulcers. This study assessed whether the combination therapy of rebamipide plus a proton pump inhibitor (PPI) offered benefits over...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Gut Liver
Auteurs principaux: Nakamura, Kazuhiko, Ihara, Eikichi, Akiho, Hirotada, Akahoshi, Kazuya, Harada, Naohiko, Ochiai, Toshiaki, Nakamura, Norimoto, Ogino, Haruei, Iwasa, Tsutomu, Aso, Akira, Iboshi, Yoichiro, Takayanagi, Ryoichi
Format: Artigo
Langue:Inglês
Publié: Editorial Office of Gut and Liver 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087931/
https://ncbi.nlm.nih.gov/pubmed/27282261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl15486
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires